FDA Warning Letter — Hikma Pharmaceuticals USA, Inc.

Case 213453 — FEI 2250102

The FDA took a Warning Letter action against Hikma Pharmaceuticals USA, Inc. on Feb 6, 2012 (Eatontown, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Hikma Pharmaceuticals USA, Inc.
Date
Feb 6, 2012
Fiscal Year
2012
Product Type
Drugs
Center
CDER
Location
Eatontown, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.